1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ACELRX PHARMACEUTICALS INC
Acelrx Pharmaceuticals Inc XNAS: ACRX
Download real time
0.85 0.03 (3.66%)
New 52W High in past week
2.7M
XNAS Volume
High vol.+gain this week

XNAS 09 Sep, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share


Insider Trading disclosures for Acelrx Pharmaceuticals Inc

The latest disclosure was made by Abhinav Jain in Acelrx Pharmaceuticals Inc where a trade of 871 Common Stock done was reported to US exchanges on Jan. 22, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Abhinav Jain Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2024 871 871 (0%) 0% 0 Common Stock
Jain Abhinav Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2024 5,228 5,228 - - Stock Option (Right to Buy)
Angotti J. Vincent Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.73 per share. 13 Dec 2023 10,000 101,805 (0%) 0% 0.7 7,268 Common Stock
Howard Rosen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Oct 2023 3,487 3,487 - - Stock Option (Right to Buy)
Howard Rosen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Oct 2023 581 5,293 (0%) 0% 0 Common Stock
Bozilenko Marina Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Oct 2023 581 2,606 (0%) 0% 0 Common Stock
Jill M. Broadfoot Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Oct 2023 3,487 3,487 - - Stock Option (Right to Buy)
Stephen J. Hoffman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Oct 2023 581 2,418 (0%) 0% 0 Common Stock
Bozilenko Marina Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Oct 2023 3,487 3,487 - - Stock Option (Right to Buy)
Hoffman J. Stephen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Oct 2023 3,487 3,487 - - Stock Option (Right to Buy)
Afable Richard Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Oct 2023 581 2,468 (0%) 0% 0 Common Stock
Afable Richard Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Oct 2023 3,487 3,487 - - Stock Option (Right to Buy)
Wan Mark A. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Oct 2023 581 2,418 (0%) 0% 0 Common Stock
Adrian Adams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Oct 2023 581 11,168 (0%) 0% 0 Common Stock
Adrian Adams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Oct 2023 3,487 3,487 - - Stock Option (Right to Buy)
Broadfoot Jill M. Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Oct 2023 581 2,106 (0%) 0% 0 Common Stock
Mark A. Wan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Oct 2023 3,487 3,487 - - Stock Option (Right to Buy)
Pamela P. Palmer Director, Chief Medical Officer Sale of securities on an exchange or to another person at price $ 1.17 per share. 24 Aug 2023 9,514 38,195 (0%) 0% 1.2 11,131 Common Stock
Pamela P. Palmer Director, Chief Medical Officer Sale of securities on an exchange or to another person at price $ 1.09 per share. 24 Aug 2023 7,442 30,753 (0%) 0% 1.1 8,104 Common Stock
Vincent J. Angotti Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.31 per share. 03 Mar 2023 1,703 63,836 (0%) 0% 1.3 2,231 Common Stock
Badri Dasu Chief Engineering Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.31 per share. 03 Mar 2023 398 18,771 (0%) 0% 1.3 521 Common Stock
Raffi Asadorian Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.31 per share. 03 Mar 2023 510 22,081 (0%) 0% 1.3 668 Common Stock
Pamela P. Palmer Director, Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.31 per share. 03 Mar 2023 570 43,315 (0%) 0% 1.3 747 Common Stock
Pamela P. Palmer Director, Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.68 per share. 10 Feb 2023 1,017 43,885 (0%) 0% 1.7 1,709 Common Stock
Vincent J. Angotti Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2023 117,000 117,000 - - Stock Option (Right to Buy)
Vincent J. Angotti Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.68 per share. 10 Feb 2023 3,321 65,539 (0%) 0% 1.7 5,579 Common Stock
Vincent J. Angotti Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2023 19,500 68,860 (0%) 0% 0 Common Stock
Badri Dasu Chief Engineering Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2023 4,875 19,945 (0%) 0% 0 Common Stock
Badri Dasu Chief Engineering Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.68 per share. 10 Feb 2023 776 19,169 (0%) 0% 1.7 1,304 Common Stock
Raffi Asadorian Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.68 per share. 10 Feb 2023 873 22,591 (0%) 0% 1.7 1,467 Common Stock
Pamela P. Palmer Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2023 6,125 44,902 (0%) 0% 0 Common Stock
Pamela P. Palmer Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2023 36,750 36,750 - - Stock Option (Right to Buy)
Raffi Asadorian Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2023 35,250 35,250 - - Stock Option (Right to Buy)
Raffi Asadorian Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2023 5,875 23,464 (0%) 0% 0 Common Stock
Badri Dasu Chief Engineering Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2023 29,250 29,250 - - Stock Option (Right to Buy)
Vincent J. Angotti Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.02 per share. 06 Feb 2023 1,982 49,360 (0%) 0% 2.0 4,004 Common Stock
Badri Dasu Chief Engineering Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.02 per share. 06 Feb 2023 458 15,070 (0%) 0% 2.0 925 Common Stock
Raffi Asadorian Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.02 per share. 06 Feb 2023 617 17,589 (0%) 0% 2.0 1,246 Common Stock
Pamela P. Palmer Director, Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.02 per share. 06 Feb 2023 681 38,777 (0%) 0% 2.0 1,376 Common Stock
Vincent J. Angotti Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.22 per share. 07 Jun 2022 46,400 1,016,919 (1%) 0% 0.2 10,333 Common Stock
Raffi Asadorian Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.41 per share. 03 Mar 2022 7,923 364,205 (0%) 0% 0.4 3,223 Common Stock
Pamela P. Palmer Director, Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.41 per share. 03 Mar 2022 7,923 779,261 (0%) 0% 0.4 3,223 Common Stock
Badri Dasu Chief Engineering Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.41 per share. 03 Mar 2022 5,612 300,595 (0%) 0% 0.4 2,283 Common Stock
Vincent J. Angotti Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.41 per share. 03 Mar 2022 23,051 970,519 (1%) 0% 0.4 9,377 Common Stock
Pamela P. Palmer Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2022 122,500 785,111 (0%) 0% 0 Common Stock
Pamela P. Palmer Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2022 245,000 245,000 - - Stock Option (Right to Buy)
Pamela P. Palmer Director, Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.40 per share. 11 Feb 2022 7,927 777,184 (0%) 0% 0.4 3,182 Common Stock
Vincent J. Angotti Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2022 390,000 1,006,628 (1%) 0% 0 Common Stock
Vincent J. Angotti Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.40 per share. 11 Feb 2022 23,058 983,570 (1%) 0% 0.4 9,255 Common Stock
Vincent J. Angotti Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2022 780,000 780,000 - - Stock Option (Right to Buy)
Badri Dasu Chief Engineering Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.40 per share. 11 Feb 2022 5,615 296,207 (0%) 0% 0.4 2,254 Common Stock
Badri Dasu Chief Engineering Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2022 195,000 195,000 - - Stock Option (Right to Buy)
Badri Dasu Chief Engineering Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2022 97,500 301,822 (0%) 0% 0 Common Stock
Raffi Asadorian Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2022 117,500 376,015 (0%) 0% 0 Common Stock
Raffi Asadorian Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2022 235,000 235,000 - - Stock Option (Right to Buy)
Raffi Asadorian Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.40 per share. 11 Feb 2022 7,927 368,080 (0%) 0% 0.4 3,182 Common Stock
Pamela P. Palmer Director, Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.43 per share. 06 Feb 2022 9,391 662,611 (0%) 0% 0.4 4,049 Common Stock
Raffi Asadorian Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.43 per share. 06 Feb 2022 9,391 258,515 (0%) 0% 0.4 4,049 Common Stock
Badri Dasu Chief Engineering Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.43 per share. 06 Feb 2022 6,830 204,322 (0%) 0% 0.4 2,945 Common Stock
Vincent J. Angotti Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.43 per share. 06 Feb 2022 27,318 616,628 (0%) 0% 0.4 11,780 Common Stock
Jill M. Broadfoot Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Nov 2021 30,000 30,000 - - Stock Option (Right to Receive)
Jill M. Broadfoot Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 20 Nov 2021 15,000 15,000 (0%) 0% 0 Common Stock
Adrian Adams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 20,000 20,000 - - Stock Option (Right to Buy)
Adrian Adams Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 10,000 196,250 (0%) 0% 0 Common Stock
Mark A. Wan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 20,000 20,000 - - Stock Option (Right to Buy)
Mark A. Wan Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 10,000 21,250 (0%) 0% 0 Common Stock
Stephen J. Hoffman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 10,000 21,250 (0%) 0% 0 Common Stock
Stephen J. Hoffman Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 20,000 20,000 - - Stock Option (Right to Buy)
Mark G. Edwards Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 20,000 20,000 - - Stock Option (Right to Buy)
Mark G. Edwards Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 10,000 261,250 (0%) 0% 0 Common Stock
Howard Rosen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 20,000 20,000 - - Stock Option (Right to Buy)
Howard Rosen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 10,000 78,750 (0%) 0% 0 Common Stock
Richard Afable Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 20,000 20,000 - - Stock Option (Right to Buy)
Richard Afable Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 10,000 22,250 (0%) 0% 0 Common Stock
Marina Bozilenko Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 20,000 20,000 - - Stock Option (Right to Buy)
Marina Bozilenko Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2021 10,000 25,000 (0%) 0% 0 Common Stock
Marina Bozilenko Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2021 30,000 30,000 - - Stock Option (Right to Buy)
Marina Bozilenko Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 Mar 2021 15,000 15,000 (0%) 0% 0 Common Stock
Pamela P. Palmer Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2021 68,750 68,750 - - Stock Option (Right to Buy)
Pamela P. Palmer Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2021 137,500 137,500 - - Stock Option (Right to Buy)
Vincent J. Angotti Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2021 1,000,000 1,000,000 - - Stock Option (Right to Buy)
Vincent J. Angotti Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2021 200,000 636,980 (0%) 0% 0 Common Stock
Badri Dasu Chief Engineering Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2021 100,000 100,000 - - Stock Option (Right to Buy)
Badri Dasu Chief Engineering Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2021 50,000 204,757 (0%) 0% 0 Common Stock
Badri Dasu Chief Engineering Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2021 50,000 50,000 - - Stock Option (Right to Buy)
Raffi Asadorian Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2021 137,500 137,500 - - Stock Option (Right to Buy)
Raffi Asadorian Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2021 68,750 68,750 - - Stock Option (Right to Buy)
Raffi Asadorian Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2021 68,750 260,597 (0%) 0% 0 Common Stock
Pamela P. Palmer Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 03 Mar 2021 68,750 666,621 (0%) 0% 0 Common Stock
Vincent J. Angotti Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.63 per share. 11 Feb 2021 23,052 427,887 (0%) 0% 2.6 60,627 Common Stock
Badri Dasu Chief Engineering Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.63 per share. 11 Feb 2021 6,775 144,757 (0%) 0% 2.6 17,818 Common Stock
Raffi Asadorian Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.63 per share. 11 Feb 2021 9,024 183,299 (0%) 0% 2.6 23,733 Common Stock
Pamela P. Palmer Director, Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.63 per share. 11 Feb 2021 8,915 593,098 (0%) 0% 2.6 23,446 Common Stock
Vincent J. Angotti Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.59 per share. 06 Feb 2021 25,059 450,939 (0%) 0% 2.6 64,903 Common Stock
Badri Dasu Chief Engineering Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.59 per share. 06 Feb 2021 6,846 151,532 (0%) 0% 2.6 17,731 Common Stock
Raffi Asadorian Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.59 per share. 06 Feb 2021 9,414 192,323 (0%) 0% 2.6 24,382 Common Stock
Pamela P. Palmer Director, Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.59 per share. 06 Feb 2021 9,414 602,013 (0%) 0% 2.6 24,382 Common Stock
Adrian Adams None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2020 7,500 186,250 (0%) 0% 0 Common Stock
Adrian Adams None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2020 15,000 15,000 - - Stock Option (Right to Buy)
Mark A. Wan None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2020 7,500 11,250 (0%) 0% 0 Common Stock
Mark A. Wan None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2020 15,000 15,000 - - Stock Option (Right to Buy)
Stephen J. Hoffman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2020 7,500 11,250 (0%) 0% 0 Common Stock
Stephen J. Hoffman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2020 15,000 15,000 - - Stock Option (Right to Buy)
Mark G. Edwards None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2020 7,500 251,250 (0%) 0% 0 Common Stock
Mark G. Edwards None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2020 15,000 15,000 - - Stock Option (Right to Buy)
Howard Rosen None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2020 15,000 15,000 - - Stock Option (Right to Buy)
Howard Rosen None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2020 7,500 68,750 (0%) 0% 0 Common Stock
Richard Afable None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2020 15,000 15,000 - - Stock Option (Right to Buy)
Richard Afable None Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2020 7,500 12,250 (0%) 0% 0 Common Stock
Adrian Adams None Purchase of securities on an exchange or from another person at price $ 1.29 per share. 15 Jun 2020 100,000 178,750 (0%) 0% 1.3 128,900 Common Stock
Vincent J. Angotti Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 1.33 per share. 15 Jun 2020 7,547 468,757 (0%) 0% 1.3 10,035 Common Stock
Vincent J. Angotti Director, Chief Executive Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.71 per share. 11 Feb 2020 23,052 452,892 (0%) 0% 1.7 39,419 Common Stock
Badri Dasu Chief Engineering Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.71 per share. 11 Feb 2020 5,613 157,654 (0%) 0% 1.7 9,598 Common Stock
Raffi Asadorian Chief Financial Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.71 per share. 11 Feb 2020 7,924 188,765 (0%) 0% 1.7 13,550 Common Stock
Pamela P. Palmer Director, Chief Medical Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.71 per share. 11 Feb 2020 7,924 604,983 (0%) 0% 1.7 13,550 Common Stock
Lawrence Hamel Chief Development Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.71 per share. 11 Feb 2020 5,613 127,769 (0%) 0% 1.7 9,598 Common Stock
Vincent J. Angotti Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2020 200,000 475,944 (0%) 0% 0 Common Stock
Vincent J. Angotti Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2020 400,000 400,000 - - Stock Option (Right to Buy)
Badri Dasu Chief Engineering Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2020 100,000 100,000 - - Stock Option (Right to Buy)
Badri Dasu Chief Engineering Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2020 50,000 163,267 (0%) 0% 0 Common Stock
Raffi Asadorian Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2020 137,500 137,500 - - Stock Option (Right to Buy)
Raffi Asadorian Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2020 68,750 196,689 (0%) 0% 0 Common Stock
Pamela P. Palmer Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2020 68,750 612,907 (0%) 0% 0 Common Stock
Pamela P. Palmer Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2020 137,500 137,500 - - Stock Option (Right to Buy)
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2020 100,000 100,000 - - Stock Option (Right to Buy)
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Feb 2020 50,000 133,382 (0%) 0% 0 Common Stock
Mark G. Edwards None Purchase of securities on an exchange or from another person at price $ 1.78 per share. 12 Nov 2019 25,000 243,750 (0%) 0% 1.8 44,575 Common Stock
Vincent J. Angotti Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 1.79 per share. 11 Nov 2019 8,379 275,944 (0%) 0% 1.8 14,973 Common Stock
Vincent J. Angotti Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2019 96,250 192,500 - - Stock Option (Right to Buy)
Badri Dasu Chief Engineering Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2019 31,625 63,250 - - Stock Option (Right to Buy)
Raffi Asadorian Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2019 40,563 81,125 - - Stock Option (Right to Buy)
Pamela P. Palmer Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2019 47,575 95,150 - - Stock Option (Right to Buy)
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2019 26,125 52,250 - - Stock Option (Right to Buy)
Mark G. Edwards None Purchase of securities on an exchange or from another person at price $ 2.17 per share. 23 Aug 2019 5,000 218,750 (0%) 0% 2.2 10,850 Common Stock
Mark G. Edwards None Purchase of securities on an exchange or from another person at price $ 2.20 per share. 23 Aug 2019 10,000 213,750 (0%) 0% 2.2 21,956 Common Stock
Adrian Adams None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2019 3,750 78,750 (0%) 0% 0 Common Stock
Adrian Adams None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2019 7,500 7,500 - - Stock Option (Right to Buy)
Mark A. Wan None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2019 3,750 3,750 (0%) 0% 0 Common Stock
Mark A. Wan None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2019 7,500 7,500 - - Stock Option (Right to Buy)
Stephen J. Hoffman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2019 7,500 7,500 - - Stock Option (Right to Buy)
Stephen J. Hoffman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2019 3,750 3,750 (0%) 0% 0 Common Stock
Mark G. Edwards None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2019 7,500 7,500 - - Stock Option (Right to Buy)
Mark G. Edwards None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2019 3,750 203,750 (0%) 0% 0 Common Stock
Howard Rosen None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2019 3,750 61,250 (0%) 0% 0 Common Stock
Howard Rosen None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2019 7,500 7,500 - - Stock Option (Right to Buy)
Richard Afable None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2019 3,750 4,750 (0%) 0% 0 Common Stock
Richard Afable None Grant, award, or other acquisition of securities at price $ 0.00 per share. 25 Jun 2019 7,500 7,500 - - Stock Option (Right to Buy)
Vincent J. Angotti Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 2.31 per share. 05 Jun 2019 5,000 262,884 (0%) 0% 2.3 11,550 Common Stock
Mark G. Edwards None Purchase of securities on an exchange or from another person at price $ 2.99 per share. 12 Mar 2019 19,000 200,000 (0%) 0% 3.0 56,890 Common Stock
Vincent J. Angotti Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 2.81 per share. 28 Feb 2019 3,234 257,884 (0%) 0% 2.8 9,088 Common Stock
Badri Dasu Chief Engineering Officer Purchase of securities on an exchange or from another person at price $ 2.81 per share. 28 Feb 2019 9,206 113,267 (0%) 0% 2.8 25,869 Common Stock
Raffi Asadorian Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 2.81 per share. 28 Feb 2019 3,647 124,397 (0%) 0% 2.8 10,248 Common Stock
Pamela P. Palmer Director, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 2.81 per share. 28 Feb 2019 840 541,724 (0%) 0% 2.8 2,360 Common Stock
Lawrence Hamel Chief Development Officer Purchase of securities on an exchange or from another person at price $ 2.81 per share. 28 Feb 2019 3,682 78,053 (0%) 0% 2.8 10,346 Common Stock
Vincent J. Angotti Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2019 200,000 254,650 (0%) 0% 0 Common Stock
Vincent J. Angotti Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2019 400,000 400,000 - - Stock Option (Right to Buy)
Badri Dasu Chief Engineering Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2019 100,000 100,000 - - Stock Option (Right to Buy)
Badri Dasu Chief Engineering Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2019 50,000 104,061 (0%) 0% 0 Common Stock
Raffi Asadorian Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2019 68,750 120,750 (0%) 0% 0 Common Stock
Raffi Asadorian Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2019 137,500 137,500 - - Stock Option (Right to Buy)
Pamela P. Palmer Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2019 68,750 540,884 (0%) 0% 0 Common Stock
Pamela P. Palmer Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2019 137,500 137,500 - - Stock Option (Right to Buy)
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2019 100,000 100,000 - - Stock Option (Right to Buy)
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2019 50,000 74,371 (0%) 0% 0 Common Stock
Stephen J. Hoffman None 31 Dec 2018 15,000 15,000 - - Stock Option (Right to Buy)
Stephen J. Hoffman None 31 Dec 2018 15,000 15,000 - - Stock Option (Right to Buy)
Stephen J. Hoffman None 31 Dec 2018 15,000 15,000 - - Stock Option (Right to Buy)
Stephen J. Hoffman None 31 Dec 2018 15,000 15,000 - - Stock Option (Right to Buy)
Stephen J. Hoffman None 31 Dec 2018 15,000 15,000 - - Stock Option (Right to Buy)
Vincent J. Angotti Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 2.78 per share. 14 Dec 2018 3,610 54,650 (0%) 0% 2.8 10,024 Common Stock
Raffi Asadorian Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 2.78 per share. 14 Dec 2018 5,000 52,000 (0%) 0% 2.8 13,883 Common Stock
Vincent J. Angotti Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 2.99 per share. 12 Dec 2018 10,000 51,040 (0%) 0% 3.0 29,890 Common Stock
Pamela P. Palmer Director, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 3.07 per share. 19 Nov 2018 16,000 472,134 (0%) 0% 3.1 49,120 Common Stock
Mark G. Edwards None Purchase of securities on an exchange or from another person at price $ 2.82 per share. 15 Nov 2018 20,700 181,000 (0%) 0% 2.8 58,376 Common Stock
Raffi Asadorian Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 3.13 per share. 13 Nov 2018 5,000 47,000 (0%) 0% 3.1 15,646 Common Stock
Vincent J. Angotti Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2018 96,250 96,250 - - Stock Option (Right to Buy)
Badri Dasu Chief Engineering Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2018 31,625 31,625 - - Stock Option (Right to Buy)
Raffi Asadorian Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2018 40,562 40,562 - - Stock Option (Right to Buy)
Pamela P. Palmer Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2018 47,575 47,575 - - Stock Option (Right to Buy)
Lawrence Hamel Chief Development Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Nov 2018 5,000 21,125 - - Stock Option (Right to Buy)
Lawrence Hamel Chief Development Officer Sale or transfer of securities back to the company at price $ 5.00 per share. 02 Nov 2018 5,000 29,795 (0%) 0% 5 25,000 Common Stock
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 2.22 per share. 02 Nov 2018 5,000 34,795 (0%) 0% 2.2 11,125 Common Stock
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Nov 2018 26,125 26,125 - - Stock Option (Right to Buy)
Badri Dasu Chief Engineering Officer Sale of securities on an exchange or to another person at price $ 5.00 per share. 15 Oct 2018 28,351 54,061 (0%) 0% 5 141,755 Common Stock
Lawrence Hamel Chief Development Officer Sale of securities on an exchange or to another person at price $ 5.00 per share. 15 Oct 2018 5,216 29,795 (0%) 0% 5 26,080 Common Stock
Lawrence Hamel Chief Development Officer Sale of securities on an exchange or to another person at price $ 4.50 per share. 24 Sep 2018 6,953 35,011 (0%) 0% 4.5 31,289 Common Stock
Vincent J. Angotti Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 1.49 per share. 31 Aug 2018 6,040 41,040 (0%) 0% 1.5 9,000 Common Stock
Badri Dasu Chief Engineering Officer Grant, award, or other acquisition of securities at price $ 1.49 per share. 31 Aug 2018 8,022 82,412 (0%) 0% 1.5 11,953 Common Stock
Raffi Asadorian Chief Financial Officer Grant, award, or other acquisition of securities at price $ 1.49 per share. 31 Aug 2018 10,000 42,000 (0%) 0% 1.5 14,900 Common Stock
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 1.49 per share. 31 Aug 2018 6,876 24,371 (0%) 0% 1.5 10,245 Common Stock
Vincent J. Angotti Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 2.90 per share. 07 Aug 2018 10,000 35,000 (0%) 0% 2.9 28,950 Common Stock
Mark G. Edwards None Purchase of securities on an exchange or from another person at price $ 2.84 per share. 07 Aug 2018 5,300 160,300 (0%) 0% 2.8 15,063 Common Stock
Raffi Asadorian Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 2.74 per share. 06 Aug 2018 5,000 32,000 (0%) 0% 2.7 13,725 Common Stock
Pamela P. Palmer Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 2.75 per share. 06 Aug 2018 37,000 456,134 (0%) 0% 2.8 101,750 Common Stock
Adrian Adams None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2018 15,000 15,000 - - Stock Options (Right to Buy)
Mark A. Wan None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2018 15,000 15,000 - - Stock Options (Right to Buy)
Mark G. Edwards None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2018 15,000 15,000 - - Stock Options (Right to Buy)
Howard Rosen None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2018 15,000 15,000 - - Stock Options (Right to Buy)
C. Hoffman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2018 15,000 15,000 - - Stock Options (Right to Buy)
Richard Afable None Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jun 2018 15,000 15,000 - - Stock Options (Right to Buy)
Mark G. Edwards None Purchase of securities on an exchange or from another person at price $ 3.35 per share. 01 Jun 2018 4,700 155,000 (0%) 0% 3.4 15,745 Common Stock
Mark G. Edwards None Purchase of securities on an exchange or from another person at price $ 3.30 per share. 01 Jun 2018 300 150,300 (0%) 0% 3.3 990 Common Stock
Raffi Asadorian Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 3.18 per share. 25 May 2018 5,000 27,000 (0%) 0% 3.2 15,923 Common Stock
Mark A. Wan Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 21 May 2018 179,962 0 (0%) 0% 0 Common Stock
Mark A. Wan Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 21 May 2018 3,347,357 0 (0%) 6% 0 Common Stock
Mark A. Wan Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 21 May 2018 5,713,569 0 (0%) 11% 0 Common Stock
Mark A. Wan Director, Ten Percent Owner Other type of transaction at price $ 0.00 per share. 21 May 2018 126,153 0 (0%) 0% 0 Common Stock
John G. Saia General Counsel and Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Apr 2018 145,000 145,000 - - Stock Option (Right to Buy)
Vincent J. Angotti Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2018 350,000 350,000 - - Stock Option (Right to Buy)
Badri Dasu Chief Engineering Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2018 115,000 115,000 - - Stock Option (Right to Buy)
Raffi Asadorian Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2018 147,500 147,500 - - Stock Option (Right to Buy)
Pamela P. Palmer Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2018 173,000 173,000 - - Stock Option (Right to Buy)
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Jan 2018 95,000 95,000 - - Stock Option (Right to Buy)
Mark G. Edwards None Purchase of securities on an exchange or from another person at price $ 1.90 per share. 14 Nov 2017 30,000 150,000 (0%) 0% 1.9 56,970 Common Stock
Raffi Asadorian Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 1.94 per share. 13 Nov 2017 5,000 12,000 (0%) 0% 1.9 9,711 Common Stock
Badri Dasu Chief Engineering Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 19 Oct 2017 37,500 0 - - Stock Option (Right to Buy)
Badri Dasu Chief Engineering Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.20 per share. 19 Oct 2017 37,500 74,390 (0%) 0% 1.2 45,000 Common Stock
Lawrence Hamel Chief Development Officer Sale of securities on an exchange or to another person at price $ 5.29 per share. 02 Oct 2017 10,161 41,964 (0%) 0% 5.3 53,752 Common Stock
Lawrence Hamel Chief Development Officer Sale of securities on an exchange or to another person at price $ 0.00 per share. 25 Sep 2017 13,827 68,504 (0%) 0% 0 Common Stock
Raffi Asadorian Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 3.24 per share. 11 Sep 2017 7,000 7,000 (0%) 0% 3.2 22,705 Common Stock
Vincent J. Angotti Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 3.00 per share. 24 Aug 2017 15,000 15,000 (0%) 0% 3 45,000 Common Stock
Mark G. Edwards None Purchase of securities on an exchange or from another person at price $ 3.02 per share. 22 Aug 2017 4,800 120,000 (0%) 0% 3.0 14,520 Common Stock
Mark G. Edwards None Purchase of securities on an exchange or from another person at price $ 2.90 per share. 22 Aug 2017 200 115,200 (0%) 0% 2.9 580 Common Stock
Pamela P. Palmer Director, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 2.95 per share. 22 Aug 2017 10,000 415,801 (0%) 0% 2.9 29,487 Common Stock
Raffi Asadorian Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Aug 2017 220,000 220,000 - - Stock Option (Right to Buy)
Adrian Adams None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2017 15,000 15,000 - - Stock Option (Right to Buy)
Mark A. Wan Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2017 15,000 15,000 - - Stock Option (Right to Buy)
Mark G. Edwards None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2017 15,000 15,000 - - Stock Option (Right to Buy)
Howard Rosen None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2017 15,000 15,000 - - Stock Option (Right to Buy)
C. Hoffman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2017 15,000 15,000 - - Stock Option (Right to Buy)
Richard Afable None Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jun 2017 15,000 15,000 - - Stock Option (Right to Buy)
Lawrence Hamel Chief Development Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 10 Apr 2017 9,122 0 - - Stock Option (Right to Buy)
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 1.20 per share. 10 Apr 2017 9,122 73,475 (0%) 0% 1.2 10,946 Common Stock
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Apr 2017 6,879 80,354 (0%) 0% 0 Common Stock
Vincent J. Angotti Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 06 Mar 2017 800,000 800,000 - - Stock Option (Right to Buy)
Timothy E. Morris Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2017 112,500 112,500 - - Common Stock (Right to Buy)
Badri Dasu Chief Engineering Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2017 79,500 79,500 - - Common Stock (Right to Buy)
Pamela P. Palmer Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2017 132,500 132,500 - - Common Stock (Right to Buy)
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2017 79,500 79,500 - - Common Stock (Right to Buy)
Howard Rosen Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2017 366,000 366,000 - - Stock Option (Right to Buy)
Jane Wright Mitchell Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2017 79,500 79,500 - - Common Stock (Right to Buy)
Mark G. Edwards None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2016 15,000 15,000 - - Common Stock (Right to Buy)
C. Hoffman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2016 15,000 15,000 - - Common Stock (Right to Buy)
Mark A. Wan Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2016 15,000 15,000 - - Common Stock (Right to Buy)
Adrian Adams None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2016 15,000 15,000 - - Common Stock (Options to Buy)
Richard Afable None Grant, award, or other acquisition of securities at price $ 0.00 per share. 21 Jun 2016 15,000 15,000 - - Common Stock (Right to Buy)
Howard Rosen Director, CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 13 May 2016 10,206 50,000 - - Common Stock
Mark G. Edwards None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 May 2016 5,000 105,000 - - Common Stock
Mark G. Edwards None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 May 2016 5,000 110,000 - - Common Stock
Mark G. Edwards None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 10 May 2016 5,000 115,000 - - Common Stock
Howard Rosen Director, CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 28 Mar 2016 800,000 800,000 - - Stock Option (Right to Buy)
Timothy E. Morris Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2016 110,500 110,500 - - Common Stock (Right to Buy)
Badri Dasu Chief Engineering Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2016 70,000 70,000 - - Common Stock (Right to Buy)
Pamela Palmer Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2016 110,500 110,500 - - Common Stock (Right to Buy)
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2016 70,000 70,000 - - Common Stock (Right to Buy)
Jane Wright Mitchell Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Feb 2016 90,000 90,000 - - Common Stock (Right to Buy)
Pamela Palmer Director, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Aug 2015 29,000 221,000 - - Stock Option (Right to Buy)
Pamela Palmer Director, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Aug 2015 29,000 399,015 - - Common Stock
Mark G. Edwards None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2015 15,000 15,000 - - Common Stock (Right to Buy)
C. Hoffman None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2015 15,000 15,000 - - Common Stock (Right to Buy)
Mark A. Wan Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2015 15,000 15,000 - - Common Stock (Option to Buy)
Adrian Adams None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2015 15,000 15,000 - - Common Stock (Option to Buy)
Richard Afable None Grant, award, or other acquisition of securities at price $ 0.00 per share. 23 Jun 2015 15,000 15,000 - - Common Stock (Right to Buy)
Howard Rosen Director, Intermin CEO Purchase of securities on an exchange or from another person at price $ 0.00 per share. 19 May 2015 35,400 39,794 - - Common Stock
Mark G. Edwards None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 May 2015 40,000 100,000 - - Common Stock
Timothy E. Morris Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 Apr 2015 100,000 100,000 - - Common Stock (Right to Buy)
Howard Rosen Director, Intermin CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2015 240,000 240,000 - - Stock Option (Right to Buy)
Pamela Palmer Director, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Mar 2015 25,000 0 - - Stock Option (Right to Buy)
Pamela Palmer Director, Chief Medical Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 12 Mar 2015 25,000 370,015 - - Common Stock
Timothy E. Morris Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Dec 2014 100,000 100,000 - - Common Stock (Right to Buy)
Badri Dasu Chief Engineering Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Dec 2014 70,000 70,000 - - Common Stock (Right to Buy)
Pamela Palmer Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Dec 2014 110,000 110,000 - - Common Stock (Right to Buy)
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Dec 2014 70,000 70,000 - - Common Stock (Right to Buy)
Jane Wright Mitchell Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Dec 2014 70,000 70,000 - - Common Stock (Right to Buy)
Mark G. Edwards None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2014 15,000 15,000 - - Stock Option (Right to Buy)
C. Hoffman Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2014 15,000 15,000 - - Stock Option (Right to Buy)
Mark A. Wan Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2014 15,000 15,000 - - Stock Option (right to buy)
Adrian Adams None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2014 15,000 15,000 - - Stock Option (Right to Buy)
Howard Rosen None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2014 15,000 15,000 - - Stock Option (Right to Buy)
Richard Afable None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2014 15,000 15,000 - - Stock Option (Right to Buy)
Jane Wright Mitchell Chief Legal Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2014 65,000 65,000 - - Stock Option (Right to Buy)
Lawrence Hamel Chief Development Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Jul 2014 3,962 9,122 - - Stock Option (Right to Buy)
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jul 2014 3,962 65,353 - - Common Stock
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jul 2014 1,000 64,353 - - Common Stock
Richard Afable None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Jun 2014 1,000 1,000 - - Common Stock
Lawrence Hamel Chief Development Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Jun 2014 4,354 13,084 - - Stock Option (Right to Buy)
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jun 2014 4,354 62,391 - - Common Stock
Lawrence Hamel Chief Development Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Jun 2014 1,000 61,391 - - Common Stock
Lawrence Hamel Chief Development Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 19 May 2014 2,346 0 - - Stock Option (Right to Buy)
Lawrence Hamel Chief Development Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 19 May 2014 1,312 17,438 - - Stock Option (Right to Buy)
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 May 2014 3,658 59,037 - - Common Stock
Lawrence Hamel Chief Development Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 19 May 2014 1,000 58,037 - - Common Stock
Timothy E. Morris Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 May 2014 200,000 200,000 - - Stock Option (Right to Buy)
Lawrence Hamel Chief Development Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Apr 2014 4,329 2,346 - - Stock Option (Right to Buy)
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Apr 2014 4,329 56,379 - - Common Stock
Lawrence Hamel Chief Development Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Apr 2014 1,000 55,379 - - Common Stock
Lawrence Hamel Chief Development Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Mar 2014 2,911 0 - - Stock Option (Right to Buy)
Lawrence Hamel Chief Development Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Mar 2014 2,305 6,675 - - Stock Option (Right to Buy)
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Mar 2014 5,216 53,050 - - Common Stock
Lawrence Hamel Chief Development Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Mar 2014 1,000 52,050 - - Common Stock
John G. Freund Other Other type of transaction at price $ 0.00 per share. 07 Mar 2014 1,300,000 2,871,933 - - Common Stock
Mark G. Edwards None Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Mar 2014 11,666 3,334 - - Stock Option (Right to Buy)
Mark G. Edwards None Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Mar 2014 9,375 3,125 - - Stock Option (Right to Buy)
Mark G. Edwards None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2014 11,666 71,666 - - Common Stock
Mark G. Edwards None Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Mar 2014 9,375 81,041 - - Common Stock
Mark G. Edwards None Sale or transfer of securities back to the company at price $ 0.00 per share. 07 Mar 2014 21,041 60,000 - - Common Stock
Stephen J. Hoffman None Other type of transaction at price $ 0.00 per share. 07 Mar 2014 1,300,000 2,871,933 - - Common Stock
Mark A. Wan Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 07 Mar 2014 46,661 3,658,051 - - Common Stock
Mark A. Wan Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 07 Mar 2014 12,186 3,645,865 - - Common Stock
Mark A. Wan Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 07 Mar 2014 298,508 3,347,357 - - Common Stock
Mark A. Wan Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 07 Mar 2014 2,508 196,666 - - Common Stock
Mark A. Wan Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 07 Mar 2014 655 196,011 - - Common Stock
Mark A. Wan Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 07 Mar 2014 16,049 179,962 - - Common Stock
Mark A. Wan Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 07 Mar 2014 79,645 6,243,889 - - Common Stock
Mark A. Wan Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 07 Mar 2014 20,800 6,223,089 - - Common Stock
Mark A. Wan Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 07 Mar 2014 509,520 5,713,569 - - Common Stock
Mark A. Wan Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 07 Mar 2014 1,759 137,862 - - Common Stock
Mark A. Wan Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 07 Mar 2014 459 137,403 - - Common Stock
Mark A. Wan Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 07 Mar 2014 11,250 126,153 - - Common Stock
Badri Dasu Chief Engineering Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 02 Mar 2014 1,000 23,910 - - Common Stock
Badri Dasu Chief Engineering Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 02 Mar 2014 1,380 22,530 - - Common Stock
Richard A. King None Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 02 Mar 2014 11,599 134,567 - - Common Stock
Lawrence Hamel Chief Development Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 02 Mar 2014 1,569 47,834 - - Common Stock
James H. Welch Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2014 75,000 75,000 - - Stock Option (Right to Buy)
Badri Dasu Chief Engineering Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2014 60,000 60,000 - - Stock Option (Right to Buy)
Richard A. King None Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2014 175,000 175,000 - - Common Stock (Right to Buy)
Pamela Palmer Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2014 100,000 100,000 - - Common Stock (Right to Buy)
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2014 60,000 60,000 - - Stock Option (Right to Buy)
David H. Chung Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 04 Feb 2014 25,000 25,000 - - Stock Option (Right to Buy)
Lawrence Hamel Chief Development Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 18 Jan 2014 4,878 2,911 - - Stock Option (Right to Buy)
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Jan 2014 4,878 47,880 - - Common Stock
Lawrence Hamel Chief Development Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 18 Jan 2014 1,000 46,880 - - Common Stock
Lawrence Hamel Chief Development Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Jan 2014 5,283 7,789 - - Stock Option (Right to Buy)
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Jan 2014 5,283 44,002 - - Common Stock
Lawrence Hamel Chief Development Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Jan 2014 1,000 43,002 - - Common Stock
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Dec 2013 4,058 39,719 - - Common Stock
Lawrence Hamel Chief Development Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Dec 2013 1,000 38,719 - - Common Stock
Lawrence Hamel Chief Development Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Dec 2013 4,058 13,072 - - Stock Option (Right to Buy)
Richard Afable None Grant, award, or other acquisition of securities at price $ 0.00 per share. 10 Dec 2013 15,000 15,000 - - Stock Option (Right to Buy)
Lawrence Hamel Chief Development Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 18 Nov 2013 1,000 35,661 - - Common Stock
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 18 Nov 2013 3,433 36,661 - - Common Stock
Lawrence Hamel Chief Development Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 18 Nov 2013 3,433 17,130 - - Stock Option (Right to Buy)
Edelman Joseph Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Nov 2013 6,500 6,474,060 - - Common Stock
Edelman Joseph Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Nov 2013 93,500 6,467,560 - - Common Stock
Edelman Joseph Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Nov 2013 6,500 6,574,060 - - Common Stock
Edelman Joseph Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Nov 2013 93,500 6,567,560 - - Common Stock
Edelman Joseph Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 04 Nov 2013 46,750 6,370,810 - - Common Stock
Edelman Joseph Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 04 Nov 2013 6,825 6,324,060 - - Common Stock
Edelman Joseph Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 04 Nov 2013 3,250 6,374,060 - - Common Stock
Edelman Joseph Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 04 Nov 2013 98,175 6,317,235 - - Common Stock
Edelman Joseph Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 31 Oct 2013 150,218 6,219,060 - - Common Stock
Edelman Joseph Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 31 Oct 2013 10,442 6,068,842 - - Common Stock
Edelman Joseph Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 31 Oct 2013 192,000 6,050,400 - - Common Stock
Edelman Joseph Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 31 Oct 2013 8,000 6,058,400 - - Common Stock
Lawrence Hamel Chief Development Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Oct 2013 1,000 33,228 - - Common Stock
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Oct 2013 3,520 34,228 - - Common Stock
Lawrence Hamel Chief Development Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Oct 2013 3,520 20,563 - - Stock Option (Right to Buy)
Guy P. Nohra None Sale of securities on an exchange or to another person at price $ 0.00 per share. 19 Sep 2013 96,519 2,507,974 - - Common Stock
Guy P. Nohra None Sale of securities on an exchange or to another person at price $ 0.00 per share. 19 Sep 2013 61,634 2,604,493 - - Common Stock
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Sep 2013 4,437 31,708 - - Common Stock
Lawrence Hamel Chief Development Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Sep 2013 1,000 30,708 - - Common Stock
Lawrence Hamel Chief Development Officer Sale or transfer of securities back to the company at price $ 0.00 per share. 17 Sep 2013 4,437 20,563 - - Stock Option (Right to Buy)
Guy P. Nohra None Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Sep 2013 16,398 2,778,509 - - Common Stock
Guy P. Nohra None Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Sep 2013 49,921 2,728,588 - - Common Stock
Guy P. Nohra None Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Sep 2013 62,461 2,666,127 - - Common Stock
Mark G. Edwards None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2013 15,000 15,000 - - Stock Option (Right to Buy)
Stephen J. Hoffman Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 12 Sep 2013 15,000 15,000 - - Stock Option (right to buy)
Mark A. Wan Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2013 15,000 15,000 - - Stock Option (right to buy)
Guy P. Nohra None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2013 15,000 15,000 - - Stock Option (Right to Buy)
Adrian Adams None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 12 Sep 2013 15,000 15,000 - - Stock Option (Right to Buy)
Howard Rosen None Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2013 15,000 15,000 - - Stock Option (Right to Buy)
David H. Chung Chief Commercial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 12 Sep 2013 150,000 150,000 - - Stock Option (Right to Buy)
Edelman Joseph Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 23 Jul 2013 850,000 5,858,400 - - Common Stock
Mark G. Edwards None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Jun 2013 10,000 60,000 - - Common Stock
Adrian Adams None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 May 2013 50,000 75,000 - - Common Stock
Adrian Adams None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 May 2013 25,000 25,000 - - Common Stock
Badri Dasu Chief Engineering Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 02 Mar 2013 1,363 18,139 - - Common Stock
Lawrence Hamel Chief Development Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 02 Mar 2013 1,549 26,578 - - Common Stock
Adrian Adams None Grant, award, or other acquisition of securities at price $ 0.00 per share. 11 Feb 2013 15,000 15,000 - - Stock Option (Right to Buy)
James H. Welch Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2013 141,775 141,775 - - Stock Option (Right to Buy)
Badri Dasu Chief Engineering Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2013 131,316 131,316 - - Stock Option (Right to Buy)
Richard A. King None Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2013 507,057 507,057 - - Common Stock (Right to Buy)
Pamela Palmer Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2013 388,137 388,137 - - Common Stock (Right to Buy)
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 05 Feb 2013 124,343 124,343 - - Stock Option (Right to Buy)
Mark A. Wan Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 Dec 2012 52,213 139,621 - - Common Stock
Mark A. Wan Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 07 Dec 2012 2,364,705 6,323,534 - - Common Stock
Mark A. Wan Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Jul 2012 12,500 12,500 - - Stock Option (right to buy)
Mark G. Edwards None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2012 12,500 12,500 - - Stock Option (Right to Buy)
Stephen J. Hoffman Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2012 12,500 12,500 - - Stock Option (right to buy)
Thomas A. Schreck None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2012 12,500 12,500 - - Stock Option (Right to Buy)
Guy P. Nohra Director, Ten Percent Owner Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2012 12,500 12,500 - - Stock Option (right to buy)
Howard Rosen None Grant, award, or other acquisition of securities at price $ 0.00 per share. 24 Jul 2012 12,500 12,500 - - Stock Option (Right to Buy)
Stephen J. Hoffman Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 29 May 2012 256,228 256,228 - - Warrant to purchase Common Stock
Stephen J. Hoffman Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 29 May 2012 284,698 4,161,933 - - Common Stock
Mark A. Wan Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 29 May 2012 208,911 3,958,829 - - Common Stock
Mark A. Wan Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 29 May 2012 60,789 60,789 - - Warrant to purchase Common Stock
Mark A. Wan Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 29 May 2012 67,543 3,704,712 - - Common Stock
Mark A. Wan Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 29 May 2012 4,151 4,151 - - Warrant to purchase Common Stock
Mark A. Wan Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 29 May 2012 188,020 188,020 - - Warrant to purchase Common Stock
Mark A. Wan Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 29 May 2012 3,268 3,268 - - Warrant to purchase Common Stock
Mark A. Wan Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 29 May 2012 4,613 87,408 - - Common Stock
Mark A. Wan Director, Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 29 May 2012 3,631 199,174 - - Common Stock
Badri Dasu Chief Engineering Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 02 Mar 2012 1,511 12,006 - - Common Stock
Lawrence Hamel Chief Development Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 02 Mar 2012 1,540 13,820 - - Common Stock
Richard A. King Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2012 262,214 262,214 - - Common Stock (Right to Buy)
James H. Welch Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2012 72,579 72,579 - - Stock Option (Right to Buy)
Badri Dasu Chief Engineering Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2012 51,319 51,319 - - Stock Option (Right to Buy)
Pamela Palmer Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2012 231,911 231,911 - - Common Stock (Right to Buy)
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2012 51,319 51,319 - - Stock Option (Right to Buy)
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Feb 2012 51,319 51,319 - - Stock Option (Right to Buy)
Mark G. Edwards None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 01 Dec 2011 10,000 50,000 - - Common Stock
Mark G. Edwards None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 14 Nov 2011 40,000 40,000 - - Common Stock
Mark G. Edwards None Grant, award, or other acquisition of securities at price $ 0.00 per share. 26 Sep 2011 15,000 15,000 - - Stock Option (Right to Buy)
James H. Welch Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Sep 2011 7,000 12,000 - - Common Stock
James H. Welch Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Sep 2011 2,000 14,000 - - Common Stock
James H. Welch Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 06 Sep 2011 1,000 15,000 - - Common Stock
Badri Dasu Chief Engineering Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 02 Sep 2011 1,354 13,517 - - Common Stock
Lawrence Hamel Chief Development Officer Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. 02 Sep 2011 1,539 15,360 - - Common Stock
Thomas A. Schreck None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 29 Aug 2011 500 300,951 - - Common Stock
Thomas A. Schreck None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 29 Aug 2011 500 17,982 - - Common Stock
Thomas A. Schreck None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Aug 2011 1,000 300,451 - - Common Stock
Thomas A. Schreck None Purchase of securities on an exchange or from another person at price $ 0.00 per share. 24 Aug 2011 1,000 17,482 - - Common Stock
Richard A. King Director, Chief Executive Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 Jun 2011 3,500 126,957 - - Common Stock
Pamela Palmer Director, Chief Medical Officer Purchase of securities on an exchange or from another person at price $ 0.00 per share. 09 Jun 2011 8,800 326,394 - - Common Stock
Thomas A. Schreck None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2011 59,145 358,596 - - Common Stock
James H. Welch Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2011 25,000 25,000 - - Stock Option (Right to Buy)
Badri Dasu Chief Engineering Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2011 12,500 12,500 - - Stock Option (Right to Buy)
Badri Dasu Chief Engineering Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2011 40,000 40,000 - - Stock Option (Right to Buy)
Badri Dasu Chief Engineering Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2011 14,871 14,871 - - Common Stock
Richard A. King Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2011 123,457 123,457 - - Common Stock
Richard A. King Director, President and CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2011 115,208 115,208 - - Stock Option (Right to Buy)
Pamela Palmer Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2011 75,000 75,000 - - Stock Option (Right to Buy)
Pamela Palmer Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2011 25,000 25,000 - - Stock Option (Right to Buy)
Pamela Palmer Director, Chief Medical Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2011 67,594 317,594 - - Common Stock
Howard Rosen None Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2011 4,394 4,394 - - Common Stock
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2011 20,000 20,000 - - Stock Option (Right to Buy)
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2011 11,000 11,000 - - Stock Option (Right to Buy)
Lawrence Hamel Chief Development Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 02 Mar 2011 16,899 16,899 - - Common Stock
Jean Deleage Ten Percent Owner 16 Feb 2011 682,904 682,904 - - Common Stock
Jean Deleage Ten Percent Owner 16 Feb 2011 328,064 1,010,968 - - Common Stock
Jean Deleage Ten Percent Owner 16 Feb 2011 810,129 1,821,097 - - Common Stock
Jean Deleage Ten Percent Owner 16 Feb 2011 279,097 2,100,194 - - Common Stock
Jean Deleage Ten Percent Owner 16 Feb 2011 14,713 2,114,897 - - Common Stock
Jean Deleage Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Feb 2011 680,000 2,794,907 - - Common Stock
Jean Deleage Ten Percent Owner 16 Feb 2011 500,000 0 - - Series A Convertible Prefered Stock
Jean Deleage Ten Percent Owner 16 Feb 2011 218,750 0 - - Series B Convertible Preferred Stock
Jean Deleage Ten Percent Owner 16 Feb 2011 810,129 0 - - Series C Convertible Preferred Stock
Jean Deleage Ten Percent Owner Other type of transaction at price $ 0.00 per share. 16 Feb 2011 40,865 69,588 - - Warrant to Purchase Series C Convertible Preferred Stock
Jean Deleage Ten Percent Owner 16 Feb 2011 69,588 0 - - Warrant to Purchase Series C Convertible Preferred Stock
Jean Deleage Ten Percent Owner 16 Feb 2011 69,588 0 - - Series C Convertible Preferred Stock
Jean Deleage Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Feb 2011 54,875 14,713 - - Series C Convertible Preferred Stock
Jean Deleage Ten Percent Owner 16 Feb 2011 14,713 0 - - Series C Convertible Preferred Stock
Mark A. Wan Ten Percent Owner 16 Feb 2011 22,959 0 - - Series A Convertible Preferred Stock
Mark A. Wan Ten Percent Owner 16 Feb 2011 427,040 0 - - Series A Convertible Preferred Stock
Mark A. Wan Ten Percent Owner 16 Feb 2011 16,741 0 - - Series B Convertible Preferred Stock
Mark A. Wan Ten Percent Owner 16 Feb 2011 311,384 0 - - Series B Convertible Preferred Stock
Mark A. Wan Ten Percent Owner 16 Feb 2011 44,702 0 - - Series C Convertible Preferred Stock
Mark A. Wan Ten Percent Owner 16 Feb 2011 831,466 0 - - Series C Convertible Preferred Stock
Mark A. Wan Ten Percent Owner 16 Feb 2011 6,135 0 - - Warrant to purchase Series C Convertible Preferred Stock
Mark A. Wan Ten Percent Owner 16 Feb 2011 6,135 6,135 - - Series C Convertible Preferred Stock
Mark A. Wan Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Feb 2011 4,838 1,297 - - Series C Convertible Preferred Stock
Mark A. Wan Ten Percent Owner 16 Feb 2011 1,297 0 - - Series C Convertible Preferred Stock
Mark A. Wan Ten Percent Owner 16 Feb 2011 114,123 0 - - Warrant to purchase Series C Convertible Preferred Stock
Mark A. Wan Ten Percent Owner 16 Feb 2011 114,123 114,123 - - Series C Convertible Preferred Stock
Mark A. Wan Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Feb 2011 89,993 24,130 - - Series C Convertible Preferred Stock
Mark A. Wan Ten Percent Owner 16 Feb 2011 31,357 31,357 - - Common Stock
Mark A. Wan Ten Percent Owner 16 Feb 2011 583,255 583,255 - - Common Stock
Mark A. Wan Ten Percent Owner 16 Feb 2011 25,106 56,463 - - Common Stock
Mark A. Wan Ten Percent Owner 16 Feb 2011 466,990 1,050,245 - - Common Stock
Mark A. Wan Ten Percent Owner 16 Feb 2011 44,702 101,165 - - Common Stock
Mark A. Wan Ten Percent Owner 16 Feb 2011 831,466 1,881,711 - - Common Stock
Mark A. Wan Ten Percent Owner 16 Feb 2011 27,142 128,307 - - Common Stock
Mark A. Wan Ten Percent Owner 16 Feb 2011 504,860 2,386,571 - - Common Stock
Mark A. Wan Ten Percent Owner 16 Feb 2011 1,430 129,737 - - Common Stock
Mark A. Wan Ten Percent Owner 16 Feb 2011 26,615 2,413,186 - - Common Stock
Mark A. Wan Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Feb 2011 65,806 195,543 - - Common Stock
Mark A. Wan Ten Percent Owner Purchase of securities on an exchange or from another person at price $ 0.00 per share. 16 Feb 2011 1,223,983 3,637,169 - - Common Stock
Mark A. Wan Ten Percent Owner 16 Feb 2011 24,130 0 - - Series C Convertible Preferred Stock
Mark A. Wan Ten Percent Owner Other type of transaction at price $ 0.00 per share. 16 Feb 2011 631 631 - - Warrant to purchase Series C Convertible Preferred Stock
Mark A. Wan Ten Percent Owner 16 Feb 2011 631 0 - - Warrant to purchase Series C Convertible Preferred Stock
Mark A. Wan Ten Percent Owner 16 Feb 2011 631 631 - - Series C Convertible Preferred Stock
Mark A. Wan Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Feb 2011 498 133 - - Series C Convertible Preferred Stock
Mark A. Wan Ten Percent Owner 16 Feb 2011 133 0 - - Series C Convertible Preferred Stock
Mark A. Wan Ten Percent Owner Other type of transaction at price $ 0.00 per share. 16 Feb 2011 11,754 11,754 - - Warrant to purchase Series C Convertible Preferred Stock
Mark A. Wan Ten Percent Owner 16 Feb 2011 11,754 0 - - Warrant to purchase Series C Convertible Preferred Stock
Mark A. Wan Ten Percent Owner 16 Feb 2011 11,754 11,174 - - Series C Convertible Preferred Stock
Mark A. Wan Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Feb 2011 9,269 2,485 - - Series C Convertible Preferred Stock
Mark A. Wan Ten Percent Owner 16 Feb 2011 2,485 0 - - Series C Convertible Preferred Stock
Stephen J. Hoffman Ten Percent Owner 16 Feb 2011 500,000 0 - - Series A Convertible Preferred Stock
Stephen J. Hoffman Ten Percent Owner 16 Feb 2011 312,500 0 - - Series B Convertible Preferred Stock
Stephen J. Hoffman Ten Percent Owner 16 Feb 2011 915,798 0 - - Series C Convertible Preferred Stock
Stephen J. Hoffman Ten Percent Owner 16 Feb 2011 125,386 0 - - Warrant to purchase Series C Convertible Preferred Stock
Stephen J. Hoffman Ten Percent Owner 16 Feb 2011 125,386 125,386 - - Series C Convertible Preferred Stock
Stephen J. Hoffman Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Feb 2011 98,875 26,511 - - Series C Convertible Preferred Stock
Stephen J. Hoffman Ten Percent Owner 16 Feb 2011 26,511 0 - - Series C Convertible Preferred Stock
Stephen J. Hoffman Ten Percent Owner Other type of transaction at price $ 0.00 per share. 16 Feb 2011 12,914 12,914 - - Warrant to purchase Series C Convertible Preferred Stock
Stephen J. Hoffman Ten Percent Owner 16 Feb 2011 12,914 0 - - Warrant to purchase Series C Convertible Preferred Stock
Stephen J. Hoffman Ten Percent Owner 16 Feb 2011 12,914 12,914 - - Series C Convertible Preferred Stock
Stephen J. Hoffman Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 16 Feb 2011 10,184 2,730 - - Series C Convertible Preferred Stock
Stephen J. Hoffman Ten Percent Owner 16 Feb 2011 2,730 0 - - Series C Convertible Preferred Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters